The Chamber of Commerce and Industry in Tunisia, in partnership with the Ministry of Industry, Mines, and Energy, is organizing a high-level symposium in the capital on October 8, 2026. The event aims to explore the prospects and challenges of digital transformation in the pharmaceutical industry. The symposium, titled "The Pharmaceutical Industry in Tunisia: Transitioning to the Electronic Common Technical Document (eCTD), Digitalization, and Sustainable Competitiveness," will bring together government officials, researchers, laboratory representatives, pharmaceutical manufacturers, and digital transformation experts.
The symposium is considered a strategic platform to discuss mechanisms for accelerating the adoption of the eCTD system as a fundamental pillar for facilitating procedures for accessing medicines to the markets and supporting national pharmaceutical sovereignty. The eCTD system is expected to play a crucial role in enhancing the efficiency and transparency of the pharmaceutical industry in Tunisia.
The event's program includes discussions on several key topics, including the state's strategic orientations for promoting the pharmaceutical industry and developing the local production system. The role of the eCTD in reducing licensing deadlines for marketing and facilitating exports will also be addressed. Furthermore, the impact of digitalization on the overall competitiveness of institutions and quality management will be examined.
The symposium will also focus on the regulatory and technical challenges associated with the comprehensive digital transformation of the sector. Participants will explore ways to overcome these challenges and ensure a smooth transition to digitalization. The event is expected to provide a platform for stakeholders to share their experiences and expertise.
The Chamber of Commerce and Industry in Tunisia and the Ministry of Industry, Mines, and Energy are working together to promote the development of the pharmaceutical industry in Tunisia. The symposium is part of their efforts to support the growth of the sector and enhance its competitiveness. The event is expected to attract a large number of participants from various backgrounds.
The digital transformation of the pharmaceutical industry in Tunisia is expected to have a positive impact on the country's healthcare sector. The adoption of the eCTD system will facilitate the registration and marketing of medicines, ultimately benefiting patients and the overall healthcare system. The symposium will provide a platform for stakeholders to discuss the future of the pharmaceutical industry in Tunisia.
Key stakeholders, including government officials, industry experts, and researchers, will gather to discuss the future of the pharmaceutical industry in Tunisia. The event aims to promote collaboration and knowledge sharing among participants. The symposium is expected to contribute to the development of a robust and competitive pharmaceutical industry in Tunisia.
Key points
- The symposium will discuss the role of the eCTD system in enhancing the efficiency and transparency of the pharmaceutical industry in Tunisia.
- The event aims to promote collaboration and knowledge sharing among stakeholders in the pharmaceutical industry.
- The digital transformation of the pharmaceutical industry in Tunisia is expected to have a positive impact on the country's healthcare sector.
